Ashfa Anwar: While The World Is Editing Genes, Sri Lanka Is Still Thawing Plasma for Hemophilia
Ashfa Anwar, Biomedical Researcher from International College of Business and Technology, shared on LinkedIn:
”While the world is editing genes, Sri Lanka is still thawing plasma.
Let that sink in for a second.
I recently did a deep dive into Hemophilia A management for a literature review and what I found was honestly shocking.
Not because of how far science has come.
But because of how unevenly that progress is distributed.
Here’s what the world looks like right now:
- From plasma-based treatments like FFP and cryprecipitate to factor replacement, recombinant therapies, and emicizumab, the newest management startergy. Care has become progressively safer, more targeted, and more effective
- Gene Therapy – now at the frontier. Using vectors to deliver a functional gene directly into hepatocytes, enabling endogenous Factor VIII production.
And Sri Lanka?
Largely still at plasma based treatments and factor replacement
Recombinant therapy and emicizumab remain limited, with emicizumab mainly reserved for severe cases or patients with inhibitors
Gene therapy is not even part of the conversation here.
This is not criticism. It is a reality check.
Because the gap here is not scientific. It is systemic.
We are not waiting for breakthroughs. They already exist.
We are waiting for access, policy, and prioritisation to catch up.
So the real question is not ‘what is the future of haemophilia care?’
It is this:
Who gets to live in that future, and who gets left behind?”

Stay updated with Hemostasis Today.
-
Aug 25, 2026, 11:41Gregory Lip: Don’t Miss – €1,000 Mechanical Thrombectomy Grant
-
Aug 25, 2026, 11:35Applications Now Open for ASH26 Scientific Workshops
-
Aug 25, 2026, 11:34Louise St. Germain Bannon: ISTH is Looking for a Director of Strategic Partnerships and Business Development
-
Aug 25, 2026, 11:25Wolfgang Miesbach: Haemophilia and Ageing – A Joint ISTH/EAHAD Session at ISTH 2026
-
Aug 25, 2026, 11:18Caitlin Raymond: Your Blood Type Doesn’t Define Your Personality
-
Aug 25, 2026, 11:18N. Mariana S. Vasquez: USMLE Key Differences – Marfan Syndrome vs. Homocystinuria
-
Aug 25, 2026, 11:16Miguel Bronchud: Making Monoclonal Antibodies Safer in Pregnancy
-
Aug 25, 2026, 11:14Natalie Arnold: Germany Recognizes Low-Dose Colchicine in CVD Prevention
-
Aug 25, 2026, 11:08William Aird: Iron Deficiency vs. Inflammation – Look at the Minivans